PGR and breast cancer: Additionally, some oncogenic miRNAs interfere with ERα-dependent signaling pathways, which, in consequence, may result in partial loss of ERα functionality reflected by loss of PgR expression in BC (i.e., acquisition of ER(+)/PgR(−) phenotype).